Pre-treatment tumor size impacts on response to nivolumab in head and neck squamous cell carcinoma. 【雑誌】Auris Nasus Larynx. 2020 Feb 5. https://www.aurisnasuslarynx.com/article/S0385-8146(20)30023-7/fulltext 【インパクトファクター】1.4…

Development and validation of a prognostic model for patients with advanced lung cancer treated with the immune checkpoint inhibitor atezolizumab. 【雑誌】 Clin Cancer Res. 2020 Feb 21. pii: clincanres.2968.2019 https://clincancerres.aacrj…